Medicare Enrolled
Dr. Luis Campos, M. D.
Hematology & Oncology · Houston, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Mixed engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Campos from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Campos?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Campos
Dr. Luis Campos is a hematology & oncology specialist in Houston, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Campos performed 2,091 Medicare services across 300 unique beneficiaries.
Between the years covered by Open Payments, Dr. Campos received a total of $45,376 from 102 pharmaceutical and/or device companies across 1041 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Campos is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 43% volume in TX
$45,376 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,091
Medicare services
Top 43% in TX for hematology & oncology
300
Unique beneficiaries
$30
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~105 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
1,500 | $0 | $0 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
214 | $7 | $24 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
180 | $63 | $281 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
71 | $103 | $416 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
31 | $95 | $399 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 30 | $99 | $530 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
18 | $8 | $10 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
16 | $1,186 | $6,260 |
| Blood creatinine level test A blood test that measures the amount of creatinine, a waste product from muscle wear and tear, to help assess kidney function. |
16 | $5 | $16 |
| Whole body nuclear medicine scan with CT A combined imaging procedure using nuclear medicine and CT scans to visualize the entire body. |
15 | $1,186 | $5,556 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
3.4% high complexity
73.2% medium
23.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$45,376
Total received (2018-2024)
Avg $6,482/year across 7 years
Top 13% in TX for hematology & oncology
102
Companies
1,041
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$18,687 (41.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$14,811 (32.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$11,878 (26.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,982
2023
$5,055
2022
$2,495
2021
$2,516
2020
$6,278
2019
$16,967
2018
$8,083
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AbbVie, Inc.
$10,324
AMAG Pharmaceuticals, Inc.
$5,032
Mylan Institutional Inc.
$4,616
Incyte Corporation
$2,929
Novartis Pharmaceuticals Corporation
$2,272
Janssen Biotech, Inc.
$2,104
ChromaCode, Inc
$2,000
Ipsen Biopharmaceuticals, Inc
$1,712
E.R. Squibb & Sons, L.L.C.
$1,285
Amgen Inc.
$1,108
PFIZER INC.
$944
Celgene Corporation
$881
Merck Sharp & Dohme LLC
$700
GENZYME CORPORATION
$687
Pharmacyclics LLC, An AbbVie Company
$472
Takeda Pharmaceuticals U.S.A., Inc.
$470
Genentech USA, Inc.
$469
Eisai Inc.
$375
Merck Sharp & Dohme Corporation
$362
Janssen Pharmaceuticals, Inc
$336
Taiho Oncology, Inc.
$322
AstraZeneca Pharmaceuticals LP
$272
BeiGene USA, Inc.
$250
Lilly USA, LLC
$229
Exelixis Inc.
$227
AmerisourceBergen Drug Corporation
$204
MorphoSys, US Inc.
$203
Seagen Inc.
$162
Foundation Medicine, Inc.
$159
Astellas Pharma US Inc
$157
Pharmacyclics LLC, an AbbVie Company
$154
SpringWorks Therapeutics, Inc.
$152
Daiichi Sankyo Inc.
$144
US Oncology Corporate, Inc.
$141
Siemens Medical Solutions USA, Inc.
$137
ADC Therapeutics America, Inc.
$135
Rigel Pharmaceuticals, Inc.
$126
CTI BioPharma Corp.
$121
SOBI, INC
$120
ABBVIE INC.
$116
Medtronic Vascular, Inc.
$113
TESARO, Inc.
$112
Clovis Oncology, Inc.
$105
Bayer Healthcare Pharmaceuticals Inc.
$102
Alexion Pharmaceuticals, Inc.
$102
Bayer HealthCare Pharmaceuticals Inc.
$97
Boehringer Ingelheim Pharmaceuticals, Inc.
$90
Regeneron Healthcare Solutions, Inc.
$88
Agios Pharmaceuticals, Inc.
$87
PharmaEssentia USA Corporation
$81
Boston Scientific Corporation
$71
Verastem, Inc.
$71
Blueprint Medicines Corporation
$71
Aurobindo Pharma USA, Inc.
$68
TAIHO ONCOLOGY, INC.
$67
GlaxoSmithKline, LLC.
$64
Sirtex Medical Inc
$61
Lexicon Pharmaceuticals, Inc.
$60
Acrotech Biopharma LLC
$60
Seattle Genetics, Inc.
$55
EISAI INC.
$54
Gilead Sciences, Inc.
$53
Tempus AI, Inc
$50
Adaptive Biotechnologies Corporation
$48
ARRAY BIOPHARMA INC
$47
TerSera Therapeutics LLC
$42
Pharmacosmos Therapeutics Inc.
$42
Kyowa Kirin, Inc.
$39
TOLMAR Pharmaceuticals, Inc.
$36
Puma Biotechnology, Inc.
$35
Stemline Therapeutics Inc.
$34
Mirati Therapeutics, Inc.
$32
Kite Pharma, Inc.
$30
Teva Pharmaceuticals USA, Inc.
$26
Sobi, Inc
$25
G1 Therapeutics, Inc.
$25
Myovant Sciences Inc.
$25
JAZZ PHARMACEUTICALS INC.
$24
UROGEN PHARMA, INC.
$24
Apellis Pharmaceuticals, Inc.
$24
PORTOLA PHARMACEUTICALS, INC.
$24
Secura Bio, Inc.
$23
Acceleron Pharma, Inc.
$23
Verity Pharmaceuticals Inc.
$23
PUMA BIOTECHNOLOGY, INC.
$22
EMD Serono, Inc.
$22
Biocartis US, Inc
$20
Sumitomo Pharma America, Inc.
$20
Epizyme, Inc.,
$20
Biocompatibles, Inc.
$20
Sandoz Inc.
$20
Fennec Pharmaceuticals, Inc.
$20
AbbVie Inc.
$19
ImmunoGen, Inc.
$19
Emmaus Medical, Inc.
$19
SERVIER PHARMACEUTICALS LLC
$19
Fortovia Therapeutics, Inc.
$18
Sysmex Inostics Inc
$18
Spectrum Pharmaceuticals Inc.
$18
Dova Pharmaceuticals
$16
EUSA Pharma (US) LLC
$15
INSYS Therapeutics Inc
$13
Top 3 companies account for 44.0% of total payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AFINITOR · ALIMTA · ALUNBRIG · AYVAKIT · Alecensa · Aliqopa · Aranesp · Asparlas · Azure · BALVERSA · BENDEKA · BESREMI · BEVYXXA · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Blincyto · CABLIVI · CABOMETYX · CALQUENCE · CARVYKTI · CERDELGA · COSELA · CYRAMZA · Cabometyx · ClosureFast · Copiktra · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELIGARD · ELIQUIS · ELREXFIO · ELZONRIS · EMPLICITI · ENHERTU · ENJAYMO · ENTRESTO · EPKINLY · ERLEADA · Elahere · Endari · Enhertu · Erleada · FERAHEME · FOUNDATIONONE · Fabhalta · Farydak · Fulphila · GAZYVA · GILOTRIF · HEMADY · HYQVIA · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INQOVI · INREBIC · Imbruvica · JADENU · JAKAFI · JELMYTO · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MONOFERRIC · MVASI · MYLOTARG · NERLYNX · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · Nubeqa · OGSIVEO · ONIVYDE · OPDIVO · OPDUALAG · ORGOVYX · Ogivri · Orserdu · PADCEV · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · Padcev · Pedmark · Perjeta · Polivy · Pomalyst · Poteligeo · Prolia · REBLOZYL · RETACRIT · RETEVMO · ROLVEDON · RYBREVANT · RYDAPT · Reblozyl · Revlimid · Rezlidhia · Rubraca · SANDOSTATIN · SARCLISA · SCEMBLIX · SHINGRIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · SPRYCEL · SUTENT · SYNAGIS · SYNDROS · Soltamox · Stivarga · Sylvant · TABRECTA · TAGRISSO · TALVEY · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · THERASPHERE-BIO · TIBSOVO · TUKYSA · Tavalisse · Tecentriq · TheraSphere Y90 Glass Microspheres 10 GBq · Trelstar · Trodelvy · TrueBeam · ULTOMIRIS · VENCLEXTA · VERZENIO · VONJO · VOTRIENT · VYXEOS · Vanflyta · Vectibix · Venclexta · Vonjo · XALKORI · XARELTO · XGEVA · XT CDX · XTANDI · XYNTHA · Xermelo · Xospata · Xtandi · Yescarta · ZARXIO · ZEJULA · ZYTIGA · Zevalin · Zoladex · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (41%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $2,170 per 100 Medicare services performed
Geographic Context
Hematology & oncology specialists within 10 mi
198
Per 100K population
4.2
County median income
$73,104
Nearest hospital
MEMORIAL HERMANN MEMORIAL CITY HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Campos is a mixed practice specialist, with moderate Medicare volume, with mixed engagement industry engagement in the top 13% of TX peers, with 20 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Campos experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Campos performed 1,500 contrast dye for imaging (iodine-based) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Campos receive payments from pharmaceutical companies?
Yes. Dr. Campos received a total of $45,376 from 102 companies across 1,041 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Campos's costs compare to other hematology & oncology specialists in Houston?
Dr. Campos's average Medicare payment per service is $30. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Campos) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Houston
Browse hematology & oncology specialists in Houston ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in TX
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in TX
Which TX hematology & oncology specialists receive the most from drug and device companies.
By company
AbbVie, Inc. Payments to Doctors
See all physicians who received payments from AbbVie, Inc.
By company
AMAG Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from AMAG Pharmaceuticals, Inc.
By company
Mylan Institutional Inc. Payments to Doctors
See all physicians who received payments from Mylan Institutional Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology